NewLimit

South San Francisco, CA · Founded 2021 · Privately Held (backing)

Developer of precision medicines designed for epigenetic reprogramming to restore youthful function in aging cells. NewLimit is based in South San Francisco, CA and was founded in 2021. It was valued at $1.6 billion at its early-stage round in Oct 2025, the last priced event on record. It has raised $247 million across 2 recorded rounds; the latest was a $130 million later-stage round in May 2025.

PMV mark · valuation
$1.6B
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$247.3M
Last round
Later Stage VC
May 2025

Who backs NewLimit?

24 investors
InvestorType
Khosla VenturesVenture capital
Founders FundVenture capital
Draper AssociatesVenture capital
Abstract VenturesVenture capital
Valor Equity PartnersGrowth equity
Kleiner PerkinsOther
Boost VCVenture capital
Elad GilAngel
Human CapitalVenture capital
S32Venture capital
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

NewLimit investors

24 investors are on record for NewLimit, including Khosla Ventures, Founders Fund, Draper Associates and Abstract Ventures. By type, the record holds 9 venture capital firms, 4 angel investors and 3 private investors. The later-stage round in May 2025 drew 38 investors.

Free account
More of NewLimit with a free account
  • ·The complete investor list: 24 names
  • ·Watch NewLimit: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like NewLimit. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View